<DOC>
	<DOCNO>NCT00274716</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy two investigational drug ( MK-0736 MK-0916 ) lower blood pressure body weight patient hypertension ( high blood pressure ) . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Safety Efficacy MK0736 &amp; MK0916 Patients With Hypertension ( High Blood Pressure ) ( 0736-003 ) ( COMPLETED )</brief_title>
	<detailed_description>Participants enrol study separate 2 stratum base baseline body mass index ( BMI ) assessments prior randomly assign study treatment . Study include 24-week treatment period comprise 2 phase , A B , 12 week duration .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Hypertension systolic blood pressure ( SBP ) &lt; /= 160mm Hg diastolic blood pressure ( DBP ) : 90105mm Hg Premenopausal woman patient currently take two ( 2 ) blood pressure lower medication Body Mas Index ( BMI ) &gt; 40 kg/m2 ( morbidly obese patient ) History Alcohol abuse ( &lt; 3 Years ) History diabetes , chronic kidney disease , Active liver disease , recent heart attack stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>